Phenobarbital in Nuclear Receptor Activation: An Update

5Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Phenobarbital (PB) is a commonly prescribed anti-epileptic drug that can also benefit newborns from hyperbilirubinemia. Being the first drug demonstrating hepatic induction of cytochrome P450 (CYP), PB has since been broadly used as a model compound to study xenobiotic-induced drug metabolism and clearance. Mechanistically, PB-mediated CYP induction is linked to a number of nuclear receptors, such as the constitutive androstane receptor (CAR), pregnane X receptor (PXR), and estrogen receptor a, with CAR being the predominant regulator. Unlike prototypical agonistic ligands, PB-mediated activation of CAR does not involve direct binding with the receptor. Instead, dephosphorylation of threonine 38 in the DNA-binding domain of CAR was delineated as a key signaling event underlying PB-mediated indirect activation of CAR. Further studies revealed that such phosphorylation sites appear to be highly conserved among most human nuclear receptors. Interestingly, while PB is a pan-CAR activator in both animals and humans, PB activates human but not mouse PXR. The species-specific role of PB in gene regulation is a key determinant of its implication in xenobiotic metabolism, drug–drug interactions, energy homeostasis, and cell proliferation. In this review, we summarize the recent progress in our understanding of PB-provoked transactivation of nuclear receptors with a focus on CAR and PXR.

References Powered by Scopus

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions

1432Citations
N/AReaders
Get full text

Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands

765Citations
N/AReaders
Get full text

The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity

744Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes

13Citations
N/AReaders
Get full text

Prescriptions of CYP3A4- and P-gp inducers for patients on direct oral anticoagulants: Bridging the gap between epidemiology and patient management for optimal thromboembolic event prevention

0Citations
N/AReaders
Get full text

Hepatic Gene Expression and Metabolite Profiles of Androstenone and Skatole Relative to Plasma Estrone Sulfate Levels in Boars

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Men, S., & Wang, H. (2023, February 1). Phenobarbital in Nuclear Receptor Activation: An Update. Drug Metabolism and Disposition. American Society for Pharmacology and Experimental Therapy (ASPET). https://doi.org/10.1124/dmd.122.000859

Readers over time

‘22‘23‘24‘2502468

Readers' Seniority

Tooltip

Professor / Associate Prof. 3

50%

PhD / Post grad / Masters / Doc 3

50%

Readers' Discipline

Tooltip

Medicine and Dentistry 1

25%

Pharmacology, Toxicology and Pharmaceut... 1

25%

Social Sciences 1

25%

Materials Science 1

25%

Article Metrics

Tooltip
Mentions
News Mentions: 1
References: 1

Save time finding and organizing research with Mendeley

Sign up for free
0